Novartis Hopes For Canakinumab In Lung Cancer Nosedive

Second Phase III Fail In NSCLC

 
• By Kevin Grogan
  
Canopy
Novartis canopy program needs patching up • Source: Alamy

More from Anticancer

More from Therapy Areas